Placenta accreta and the risk of adverse maternal and neonatal outcomes
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Objective: Placenta accreta is an increasingly prevalent and potentially dangerous complication of pregnancy. Although most studies on the subject have addressed the risk factors for the development of this condition, evidence on maternal and neonatal outcomes for these pregnancies is scarce. The objective of the present study is to compile current evidence with regard to risk factors as well as adverse outcomes associated with placenta accreta. Methods: We conducted a complete literature review using PubMed, MEDLINE, Cochrane Database Reviews, UptoDate, DocGuide, as well as Google scholar and textbook literature for all articles on placenta accreta, and any one of the following keywords: “risk factors”, “maternal outcomes”, “neonatal outcomes”, “morbidity”, and “mortality”. Individual case reports were excluded. Results: We reviewed 34 studies conducted between 1977 and 2012. A total number of 508,617 deliveries were studied, with 865 cases of confirmed placenta accreta (average pooled incidence=1/588). The development of placenta accreta appears to be most strongly predicted by a history of cesarean section, low-lying placenta/previa, in vitro fertilization pregnancy, as well as elevated second-trimester levels of α-fetoprotein and β-human chorionic gonadotropin. The most significant maternal outcomes include the need for postpartum transfusion due to hemorrhage and peripartum hysterectomy. Maternal mortality remains rare but significantly higher than among matched, postpartum controls. Important neonatal outcomes include preterm birth, low birth weight, small for gestational age, and reduced 5-min Apgar scores. Whether the need for neonatal intensive care unit admission and steroid administration is iatrogenic and whether an increased risk of perinatal mortality is a clinically significant and independent outcome remain controversial. Conclusion: Although there is a significant shortage of studies on the subject, it appears that placenta accreta is associated with adverse maternal and neonatal outcomes, some of which may be life threatening. Prenatal diagnosis and adequate planning, particularly in high-risk populations, may be indicated for the reduction of these adverse outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other additional risk factors include maternal age 110,113,117,120 and ART, in particular in vitro fertilisation.113,120,122-125”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“Maternal mortality remains rare, but significantly higher than among matched postpartum controls.122”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“A review of 34 studies published between 1977 and 2012, including a total number of 508 617 deliveries and 865 cases of confirmed placenta accreta, found that the most significant maternal risks associated with delivery are the need for postpartum transfusion due to haemorrhage and peripartum hysterectomy.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“Attempts at removing placenta accreta at caesarean section can lead to massive haemorrhage, high maternal morbidity and possible maternal death.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
In the citing paper
“These risks are particularly high when the caesarean section takes place in an environment with no emergency access to blood bank products and expertise in managing placenta accreta.20,21,122,135”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [122]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries
Silver, R. M., Landon, M. B., Rouse, D. J., Leveno, K. J., Spong, C. Y., Thom, E. A., Moawad, A. H., Caritis, S. N., Harper, M., Wapner, R. J., et al. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000219750.79480.84 · Cited by 1,909 · cited 1×
“This effect is magnified when both risk factors are combined, that is, when placenta previa follows a history of cesarean section [5, 21, 31] .”
BackgroundAbnormal placentation: Twenty-year analysis
Wu, S., Kocherginsky, M., & Hibbard, J. U. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.074 · Cited by 1,331 · cited 6×
“history of cesarean section, which estimates a 2-fold risk among those with a prior cesarean section and an 8-fold risk in women with two or more prior cesarean sections [38] .”
BackgroundResultInfluentialClinical risk factors for placenta previa–placenta accreta
Miller, D. A., Chollet, J. A., & Goodwin, T. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70463-0 · Cited by 1,106 · cited 5×
“Despite its relatively low incidence and often-complex diagnosis, epidemiologic data have been consistent in establishing the risk factors associated with this condition [21, 25] .”
BackgroundResultInfluentialPlacenta previa/accreta and prior cesarean section.
Clark, S. L., Koonings, P. P., & Phelan, J. P. (1985) · PubMed · Cited by 712
Accuracy of Ultrasonography and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta
Warshak, C. R., Eskander, R., Hull, A. D., Scioscia, A. L., Mattrey, R. F., Benirschke, K., & Resnik, R. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000233155.62906.6d · Cited by 515 · cited 1×
“The sensitivity and specificity of ultrasound for detection of placenta accreta are reported to be between 77 % and 90 % and between 71 % and 98 % , respectively [35] .”
BackgroundEffect of Predelivery Diagnosis in 99 Consecutive Cases of Placenta Accreta
Warshak, C. R., Ramos, G. A., Eskander, R., Benirschke, K., Saenz, C. C., Kelly, T. F., Moore, T. R., & Resnik, R. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181c4f12a · Cited by 454 · cited 3×
“Indeed, one study reported a 44 % (4/9) rate of emergency delivery at 36 weeks for maternal hemorrhage in women with accreta/percreta who were scheduled for planned cesarean-hysterectomy at a later date [36] .”
BackgroundResultPlacenta accreta: Pathogenesis of a 20th century iatrogenic uterine disease
Jauniaux, E., & Jurkovic, D. (2012) · Placenta · doi:10.1016/j.placenta.2011.11.010 · Cited by 432
Pathophysiology of Placenta Creta: The Role of Decidua and Extravillous Trophoblast
Tantbirojn, P., Crum, C. P., & Parast, M. M. (2008) · Placenta · doi:10.1016/j.placenta.2008.04.008 · Cited by 428
Placenta Accreta—Summary of 10 Years: A Survey of 310 Cases
Gielchinsky, Y., Rojansky, N., Fasouliotis, S. J., & Ezra, Y. (2002) · Placenta · doi:10.1053/plac.2001.0764 · Cited by 376
Emergency peripartum hysterectomy
Zelop, C. M., Harlow, B. L., Frigoletto, F. D., Safon, L. E., & Saltzman, D. H. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90779-0 · Cited by 341 · cited 1×
“Poorly controlled hemorrhage is the indication for one to two thirds of peripartum hysterectomies [13, 39] .”
Background
Cited by
Jauniaux, E., Collins, S., & Burton, G. J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.05.067 · Cited by 775
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
“Maternal mortality remains rare, but significantly higher than among matched postpartum controls.(122)”
BackgroundFIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology,
Jauniaux, E., Chantraine, F., Silver, R. M., Langhoff‐Roos, J., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12407 · Cited by 498
Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis
Jauniaux, E., Bunce, C., Grønbeck, L., & Langhoff-Roos, J. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.01.233 · Cited by 356
Proposal for standardized ultrasound descriptors of abnormally invasive placenta ( AIP )
Collins, S. L., Ashcroft, A., Braun, T., Calda, P., Langhoff‐Roos, J., Morel, O., Stefanovic, V., Tutschek, B., Chantraine, F., & on behalf of the European Working Group on Abnormally Invasive Placenta (EW‐AIP) (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14952 · Cited by 331
Finken, M. J. J., van der Steen, M., Smeets, C. C. J., Walenkamp, M. J. E., de Bruin, C., Hokken-Koelega, A. C. S., & Wit, J. M. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00083 · Cited by 208
Mogos, M. F., Salemi, J. L., Ashley, M., Whiteman, V. E., & Salihu, H. M. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1034103 · Cited by 213
“Traditionally requiring peripartum hysterectomy and often associated with placenta previa [10], PA leads to severe maternal morbidity including peripartum hemorrhage requiring blood transfusion [11,12], bowel and urinary tract injury [1,13], admission to intensive care unit (ICU) [13] and prolonged hospital stay.”
BackgroundFarquhar, C. M., Li, Z., Lensen, S. F., McLintock, C., Pollock, W., Peek, M. J., Ellwood, D. A., Knight, M., Homer, C., Vaughan, G. A., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017713 · Cited by 146
“This study reports four independent risk factors for placenta accreta: older maternal age, prior caesarean section, placenta praevia diagnosed prior to birth and multiple birth; which have also been reported by other studies.(4) 27–29 Previous studies have also reported risk factors that this study did not find to be…”
BackgroundResultInfluentialMassive blood transfusion during hospitalization for delivery in New York State, 1998-2007
Mhyre, J. M., Shilkrut, A., Kuklina, E. V., Callaghan, W. M., Creanga, A. A., Kaminsky, S., & Bateman, B. T. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000021 · Cited by 121
Meng, X., Xie, L., & Song, W. (2013) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2013.05.017 · Cited by 118
New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders
Jauniaux, E., Hussein, A. M., Fox, K. A., & Collins, S. L. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.04.006 · Cited by 110
“this reflected data from referral centres, which treat more cases than in the general population (28).”
BackgroundGelany, S. E., Mosbeh, M., Ibrahim, E. M., Mohammed, M., Khalifa, E. M., Abdelhakium, A. K., Yousef, A. M., Hassan, H., Goma, K., Alghany, A. A., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2466-5 · Cited by 123
Risk factors for placenta accreta spectrum: findings from the Japan environment and Children’s study
the Japan Environment and Children’s Study (JECS) Group, Kyozuka, H., Yamaguchi, A., Suzuki, D., Fujimori, K., Hosoya, M., Yasumura, S., Yokoyama, T., Satô, A., & Hashimoto, K. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2608-9 · Cited by 109
Markley, J. C., Farber, M. K., Perlman, N. C., & Carusi, D. A. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003314 · Cited by 80
Placenta previa: an outcome-based cohort study in a contemporary obstetric population
Lal, A. K., & Hibbard, J. U. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3628-y · Cited by 65
“Detailed description of the study is provided elsewhere [11, 12].”
BackgroundKassem, G. A., & Alzahrani, A. (2013) · International Journal of Women s Health · doi:10.2147/ijwh.s53865 · Cited by 81
“We observed also that 96% of patients International Journal of Women’s Health 2013:5 submit your manuscript | www.dovepress.com Dovepress Dovepress 808 Kassem and alzahrani with PA in this study had a history of previous cesarean section with a mean number of 2.8, compared with 47.4% of patients with a mean number of…”
InfluentialTimor‐Tritsch, I. E., Calì, G., Monteagudo, A., Khatib, N., Berg, R., Forlani, F., & Avizova, E. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14708 · Cited by 62
Kütük, M. S., Ak, M., & Özgün, M. T. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12308 · Cited by 68
Invasive placental disease: the impact of a multi-disciplinary team approach to management
Smulian, J. C., Pascual, A.-L., Hesham, H., Qureshey, E., Bijoy Thomas, M., Depuy, A. M., Flicker, A. B., & Scorza, W. E. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1216099 · Cited by 57
The urologist's role in multidisciplinary management of placenta percreta
Norris, B. L., Everaerts, W., Posma, E., Murphy, D. G., Umstad, M. P., Costello, A. J., Wrede, C. D., & Kearsley, J. (2016) · BJU International · doi:10.1111/bju.13332 · Cited by 56
Shamshirsaz, A. A., Fox, K. A., Erfani, H., & Belfort, M. A. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000393 · Cited by 59
Balayla, J., Desilets, J., & Shrem, G. (2019) · Journal of Perinatal Medicine · doi:10.1515/jpm-2019-0116 · Cited by 52
Self-citationMagnetic Resonance Imaging and Sonography in the Diagnosis of Placental Invasion
Balcacer, P., Pahade, J., Spektor, M., Staib, L., Copel, J. A., & McCarthy, S. (2016) · Journal of Ultrasound in Medicine · doi:10.7863/ultra.15.07040 · Cited by 45
Assisted vaginal birth in 21st century: current practice and new innovations
Bahl, R., Hotton, E. J., Crofts, J. F., & Draycott, T. J. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.12.305 · Cited by 48
Uterine Artery Embolization before Delivery to Prevent Postpartum Hemorrhage
Niola, R., Giurazza, F., Nazzaro, G., Silvestre, M., Nasti, G., Pasquale, M. A. D., Albano, G. D., Valentino, L., Sirimarco, F., & Maglione, F. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2015.12.006 · Cited by 44
The diagnosis and management of morbidly adherent placenta
Belfort, M. A., Shamshirsaz, A. A., & Fox, K. A. (2017) · Seminars in Perinatology · doi:10.1053/j.semperi.2017.11.009 · Cited by 51
Schneiderman, M., & Balayla, J. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.770465 · Cited by 43
“Due to the inherent risk brought about this condition, as expected, we found that patients with placenta previa received closer, more comprehensive antenatal follow up [8] (Table 1).”
ResultSelf-citationAyati, S., Pourali, L., Pezeshkirad, M., Toosi, F. S., Nekooei, S., Shakeri, M. T., & Golmohammadi, M. S. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.4.225 · Cited by 46
“In literature, placenta adhesive disorder (PAD) refers to any degree of placental invasion (3).”
BackgroundNguyen, P. N., Vuong, A. D. B., & Pham, X. T. T. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06349-7 · Cited by 39
“Therefore, the neonatal outcome is a worrying issue in the context of PASDs surgery that needs a multidisciplinary team including an obstetrician, anesthetist, and neonatologist [22].”
BackgroundFetomaternal outcome in patients with placenta previa
Wasim, T., Bushra, N., Riaz, S., & Iqbal, H. I. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.5.1647 · Cited by 30
Hecht, J. L., Karumanchi, S. A., & Shainker, S. A. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05453-1 · Cited by 27
Kasraeian, M., Hashemi, A., Hessami, K., Alamdarloo, S. M., Vahdani, R., Vafaei, H., Najib, F. S., Shiravani, Z., Razavi, B., Homayoon, N., et al. (2021) · BMC Women s Health · doi:10.1186/s12905-021-01389-z · Cited by 33
“Based on a systematic review of 34 studies, maternal need of transfusion and peripartum hysterectomy were among the most prevalent and significant adverse outcomes and preterm birth, low birth weight and low 5-min Apgar score were among the most common adverse outcomes of the neonates [7].”
BackgroundDeep learning-based segmentation of the placenta and uterus on MR images
Shahedi, M., Spong, C. Y., Dormer, J. D., Do, Q. N., Xi, Y., Lewis, M. A., Herrera, C. L., Madhuranthakam, A. J., Twickler, D. M., & Fei, B. (2021) · Journal of medical imaging · doi:10.1117/1.jmi.8.5.054001 · Cited by 31
“placenta and therefore any abnormality of the placenta could be harmful to the fetus and mother.(1,2) Placenta previa, placenta accreta spectrum (PAS), and uteroplacental insufficiency are the most frequent indications for imaging studies during pregnancy.”
BackgroundPatient selection for later delivery timing with suspected previa‐accreta
Perlman, N. C., Little, S. E., Thomas, A., Cantonwine, D. E., & Carusi, D. A. (2017) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13140 · Cited by 24
Yang, T., Li, N., Hou, R., Qiao, C., & Liu, C. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-1150 · Cited by 27
“Several other risk factors have also been reported, including cryopreserved embryo transfer, older maternal age, prior uterine surgery, parity, a higher body mass index (BMI), tobacco use, coexisting hypertension or diabetes, elevated second-trimester levels of α-fetoprotein and β-human chorionic gonadotropin, and a p…”
BackgroundSandlin, A. T., Magann, E. F., Whittington, J. R., Schneider, A. M., Ramseyer, A. M., Hughes, D. S., & Ounpraseuth, S. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1903425 · Cited by 26
“713 Apgar one Minute, median [Q1, Q3] 2 [1, 6] 6 [3, 8] .”
Abnormal Placentation Associated with Infertility as a Marker of Overall Health
Sundheimer, L. W., & Pisarska, M. D. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603570 · Cited by 30
Ohira, S., Motoki, N., Shibazaki, T., Misawa, Y., Inaba, Y., Kanai, M., Kurita, H., Shiozawa, T., Nakazawa, Y., Tsukahara, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46760-1 · Cited by 27
Maternal and neonatal outcomes of abnormal placentation: a case–control study
Moeini, R., Dalili, H., Kavyani, Z., Shariat, M., Charousaei, H., Akhondzadeh, A., Naddaf, A., & Nayeri, F. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1678128 · Cited by 25
“Because of the necessity for NICU admission, the administration of corticosteroids and neonatal morbidity, which are affected by prematurity, the relationship between the neonatal outcome and these types of disorders is difficult to interpret [16].”
BackgroundThe Prenatal Diagnostic Indicators Of Placenta Accreta Spectrum
Wu, X., Yang, H., Yu, X., Zeng, J., Qiao, J., Qi, H., & Xu, H. (2022) · Heliyon · doi:10.1016/j.heliyon.2023.e16241 · Cited by 23
Cheng, H.-H., Tsang, L. L., Hsu, T., Kung, C., Ou, C., Chang, C.-D., Tsai, C., Cheng, Y., & Kung, F. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.06.011 · Cited by 20
Neonatal outcome after conservative-reconstructive surgery for placenta accreta spectrum disorders
Palacios-Jaraquemada, J. M., Basanta, N. A., Fiorillo, A., Labrousse, C., & Martínez, M. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1873944 · Cited by 22
“sion of NICU stay did not differ between the groups; this reasoning makes it likely that the neonatal outcomes are a direct consequence of iatrogenic action leading to preterm birth [13,14].”
BackgroundAnesthesia Considerations for Placenta Accreta Spectrum
Warrick, C. M., Sutton, C. D., Farber, M. K., Hess, P. E., Butwick, A. J., & Markley, J. C. (2023) · American Journal of Perinatology · doi:10.1055/s-0043-1761637 · Cited by 19
Spillane, N. T., Zamudio, S., Alvarez‐Perez, J. R., Andrews, T., Nyirenda, T. L., Alvarez, M., & Al‐Khan, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201266 · Cited by 23
Imaging Evaluation of Maternal Complications Associated with Repeat Cesarean Deliveries
Moshiri, M., Osman, S. F., Bhargava, P., Maximin, S. T., Robinson, T. J., & Katz, D. S. (2014) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2014.05.010 · Cited by 19
Blumenthal, E. A., Rao, R., Murphy, A. M., GORNBEIN, J. A., Hong, R. W., Moriarty, J. M., Kahn, D. G., & Janzen, C. (2018) · American Journal of Perinatology Reports · doi:10.1055/s-0038-1641736 · Cited by 18
Placenta accreta spectrum in subsequent pregnancy following myomectomy
Sasson, A. M., Timor, I., Meyer, R., Stockheim, D., Orvieto, R., & Mashiach, R. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1849114 · Cited by 19
“Placenta accreta spectrum (PAS) is an increasingly prevalent and potentially life-threatening complication of pregnancy [9].”
BackgroundThe risk of placenta accreta following primary cesarean delivery
Zeevi, G., Tirosh, D., Baron, J., Yitshak‐Sade, M., Segal, A., & Hershkovitz, R. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4698-4 · Cited by 20
Predelivery uterine arteries embolization in patients affected by placental implant anomalies
Giurazza, F., Albano, G. D., Valentino, L., Schena, E., Capussela, T., Pasquale, M. A. D., Pietto, F. D., Ritis, R. D., Nasti, G., Scognamiglio, G., et al. (2017) · La radiologia medica · doi:10.1007/s11547-017-0796-9 · Cited by 16
“Patients with placental implant anomalies are usually candidate to hysterectomy; a recent literature review examining 34 studies published between 1977 and 2012 reported that blood transfusions may be required in 20–70% of cases with similar values for hysterectomies performed after delivery [34].”
BackgroundConservative Surgical Management of Placenta Accreta Spectrum: A Pragmatic Approach
Sichitiu, J., El-Tani, Z., Mathevet, P., & Desseauve, D. (2019) · Journal of Investigative Surgery · doi:10.1080/08941939.2019.1623956 · Cited by 18
Hyperglycosylated hCG and Placenta Accreta Spectrum
Straubhar, A. M., Soisson, S. P., Szczotka, K. M., Dodson, M. W., Silver, R. R., Soisson, A. P., & Einerson, B. D. (2018) · American Journal of Perinatology · doi:10.1055/s-0038-1636501 · Cited by 17
AlQasem, M. H., Shaamash, A. H., Ghamdi, D. S. A., Mahfouz, A. A., & Eskandar, M. A. (2023) · Saudi Medical Journal · doi:10.15537/smj.2023.44.9.20230112 · Cited by 20
Li, J., Shi, Z., Zhu, J., Liu, J., Qiu, L., Song, Y., Wang, L., Li, Y., Liu, Y., Zhang, D., et al. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105680 · Cited by 14
Tan, J., Yang, M., Liao, Y., Qi, Y., Ren, Y., Liu, C., Huang, S., Thabane, L., Liu, X., & Sun, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-72527-0 · Cited by 16
Risk of hemorrhage in abnormally invasive placenta according to its management
Pinto, P. V., Machado, A. P., & Montenegro, N. A. M. D. M. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1240163 · Cited by 14
“AIP is currently recognized as the leading cause of emergency hysterectomy in the developed countries, and is associated with a maternal morbidity and mortality of 60% and 7%, respectively [9,10].”
Backgroundfard, M. B., Kasraeian, M., Vafaei, H., Akbarzadeh‐Jahromi, M., Arasteh, P., Shahraki, H. R., & Arasteh, P. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-2799-0 · Cited by 18
“have increased from 1 in every 2500 pregnancies since the 1990s [3] to one in every 500 to 600 pregnancies [4].”
BackgroundTitapant, V., Tongdee, T., Pooliam, J., & Wataganara, T. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1530757 · Cited by 18
Yang, T., Li, N., Qiao, C., & Liu, C. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00289 · Cited by 11
Placenta Praevia and Placenta Accreta Spectrum: Diagnosis and Management
Jauniaux, E. R. M., Bhide, A., Hussein, A. M., Lees, C. C., D'Antonio, F., Robson, S. C., Agten, A. K., & Jurkovic, D. (2026) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.70239 · Cited by 14
Stewart, M. J., Richmond, D., Mooney, S. S., Esler, S. J., Churilov, L. P., Israelsohn, N., & Yang, N. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.19.22661 · Cited by 12
Cesarean scar defects and placental abnormalities; a 3 year survey study
Bălălău, D.-O., Bacalbașa, N., & Stănescu, A. D. (2017) · Journal of Mind and Medical Sciences · doi:10.22543/7674.42.p156162 · Cited by 10
“Therefore, an important goal towards understanding placental dysfunction is to develop improved procedures for pregnancy monitoring (12).”
BackgroundBirendra, R., & Singh, J. (2023) · Cureus · doi:10.7759/cureus.44725 · Cited by 16
“Preterm birth, low birth weight, and poor 5-min Apgar scores were among the most frequent unfavourable outcomes for neonates, according to a comprehensive evaluation of 34 studies, which was also found in our study [20].”
BackgroundShuai, X., Gao, C., Zhang, H., Zhang, T., Li, H., Yan, Y., Yao, W., Liu, Y. P., & Zhang, C. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06997-9 · Cited by 10
Li, P., Tang, Y., Jiang, Y., & Li, D. (2021) · Medicine · doi:10.1097/md.0000000000025023 · Cited by 10
“In agreement, previous reports have also demonstrated the associations of placenta accreta with adverse maternal and neonatal outcomes.([20,21]) These adverse outcomes could be reduced by performing prenatal assessment and appropriate planning, especially in high-risk individuals.”
Influencing factors for placenta accreta in recent 5 years: a systematic review and meta-analysis
Hou, Y.-P., Lommel, L. L., Wiley, J. A., Zhou, X., Yao, M., Liu, S., & Peng, J. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1779215 · Cited by 9
“Both increasing numbers of CS and placenta previa have been reported as risk factors for PA in the US [13], Canada and China [5,14].”
BackgroundInfluentialPlacental pathology: A review of placenta previa, placental abruption and placenta accreta
Brennan, K. (2019) · doi:10.1029/wfsa-d-18-00010 · Cited by 8
Creating a Multidisciplinary Placenta Accreta Program
Tussey, C., & Olson, C. (2018) · Nursing for Women s Health · doi:10.1016/j.nwh.2018.08.002 · Cited by 8
Kütük, M. S., Ulu-Kılıç, A., Ak, M., & Özgün, M. T. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1465918 · Cited by 8
Losartan in patients with renal insufficiency.
de Zeeuw, D., Gansevoort, R. T., & de Jong, P. E. (1995) · PubMed · Cited by 7
Kharisma, Y., Agustina, H., Suryanti, S., Dewayani, B. M., & Hernowo, B. S. (2022) · Althea Medical Journal · doi:10.15850/amj.v9n1.2631 · Cited by 7
Comparative morphological characteristics of the uteroplacental area in abnormal placentation
Александрович, К. И., Nizyaeva, N. V., Sukhacheva, T. V., Serov, R. A., Tikhonova, N. B., Fokina, T. V., Ap, M., Николаевна, Б. Т., Milyutina, E. R., & Михалева, Л. М. (2023) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2023-8.4.8 · Cited by 7
Postpartum Hemorrhages: Prevention
Giurazza, F., Angileri, S. A., Corvino, F., Granata, G., Grillo, P., Savoldi, A. P., Albano, G. D., Bracchi, L., Carrafiello, G., & Niola, R. (2020) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2020.09.002 · Cited by 5
Mortaki, A., Douligeris, A., Panagiotopoulos, M. G., Daskalaki, M.-A., Vasilios, P., Panagiotis, A., George, D., & Marianna, T. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2024.102663 · Cited by 4
Holmes, V. J., Skinner, S., Silagy, M., Rolnik, D. L., Mol, B. W., & Kroushev, A. (2023) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13724 · Cited by 5
Elnoury, A., Webster, S., & Abdelhalim, D. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1940939 · Cited by 5
Fundal partial placenta percreta complicated with postpartum hemoperitoneum: A case report
Adwan, D., Taifour, W., Bhsass, R., & Taifour, D. (2021) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2021.106482 · Cited by 3
“Regardless of its location, abnormally invasive placenta is associated with adverse maternal and neonatal outcomes, some of which are life-threatening [4].”
BackgroundModern approach to transfusion therapy of massive hemorrhage due to abnormally invasive placenta
Golyanovskiy, O. V., Dzyuba, D. О., Morozova, О. V., Gerasimova, T., Voloshyn, O. A., Holenia, I. M., & Kononets, O. P. (2023) · Reproductive health of woman · doi:10.30841/2708-8731.5.2023.286768 · Cited by 4
Plasenta previa olgularında gebelik sonuçları
Artunç Ülkümen, B., Pala, H. G., Aktenk, F., & BAYTUR, Y. B. (2014) · Ege Tıp Dergisi · doi:10.19161/etd.344059 · Cited by 3
“bakımında yenilikler ve ekspektan tedavinin gündeme gelmesi ile 1970’li yıllarda %30 civarında seyreden perinatal mortalite oranları, 1990’lı yılların sonlarında yaklaşık olarak %0 23’lere kadar düşmüştür (18,21-25).”
Ahmed, M. A., & Khodry, M. M. (2019) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2019.97101 · Cited by 4
“It is a major cause of maternal mortality and morbidity [2].”
BackgroundSubtotal Abdominal Hysterectomy
Amarin, Z. O. (2017) · Springer eBooks · doi:10.1007/978-3-319-22497-8_87 · Cited by 3
Uterine Incision Pattern and its Effect on Maternal and Fetal Outcome in Morbidly Adherent Placenta
MIRA, M. D. E. H. M. I. M. E. A., & ELKHATEEB, M. S. A. (2022) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2022.264485 · Cited by 2
Placenta Accreta Spectrum in Normal Situated Placenta and Unscarred Uterus
Hakimi, H. M. H., Ramli, N., Napes, M. M., Wahab, W. N. N., & Rohim, R. A. A. (2023) · Oman Medical Journal · doi:10.5001/omj.2024.12 · Cited by 6
A comprehensive approach to the prevention and treatment of massive obstetric hemorrhage
Golyanovskiy, O. V., Dzyuba, D. О., Ткаченко, О. В., Zhezher, A. O., Огородник, А. О., Hubar, I., & Коvalenko, А. V. (2023) · Reproductive health of woman · doi:10.30841/2708-8731.6.2023.289994 · Cited by 3
PLASENTA AKREATA; GEÇMİŞTEN BUGÜNE ÖYKÜSÜ
Koçarslan, S. (2020) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.738885 · Cited by 2
Accuracy of MRI vs ultrasound in the diagnosis of placental adhesive disorder
Sakr, A., Ahmed, H. A. K., Ahmed, A.-E., & Ahmed, K. (2020) · Al-Azhar Assiut Medical Journal · doi:10.4103/azmj.azmj_67_20 · Cited by 2
Maternal and Perinatal Outcome of Major Degree Placenta Previa at Mansoura University Hospital
MASHALY, M. S. E. F. S., & GHANEM, M. D. M. N. A. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.62813 · Cited by 4
Khattak, S. N., Akram, U., Pervaiz, E., Anayat, M., Munir, T. A., Akhter, N., & Jan, A. A. (2018) · Journal of Bahria University Medical and Dental College · doi:10.51985/jbumdc2018064 · Cited by 2
Purnama, U., Sitepu, M., Edianto, D., Lumbanraja, S. N., Sudewo, Y., Simanjuntak, R., Lubis, M. P., & Barus, M. N. G. (2021) · Current Women s Health Reviews · doi:10.2174/1573404817666210811130136 · Cited by 2
Wasel, M., Anwar, M., & Abdel-Aziz, B. R. (2022) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2022.100728.1603 · Cited by 2
“Table (5): Multivariate regression analysis for prediction of placenta accreta using two dimensional and color Doppler ultrasound compared to surgical intervention used as the “Gold Standard”.”
MethodEl-Halim, Y. A., Kassab, F., & Sedek, A.-M. A. (2020) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2020.44790.1332 · Cited by 2
Yuliantara, E. E., Bachnas, M. A., Anggraini, N. W. P., Prabowo, W., Nugraha, G. B. A., Chasanah, M. D., Alim, F. M. S., & Merina, H. F. (2023) · PLACENTUM Jurnal Ilmiah Kesehatan dan Aplikasinya · doi:10.20961/placentum.v11i2.71047 · Cited by 1
“neonatal team will ensure high standards of care([16,54]).”
BackgroundRisk factors and maternal–neonatal outcomes of placenta accreta spectrum: A case control study
Tang, L., Shi, H., & Chen, D. (2025) · Medicine · doi:10.1097/md.0000000000044906 · Cited by 4
“[9] Ornaghi et al reported a preterm delivery rate of 51.3% in PAS cases, with a perinatal mortality rate of 2.08%.”
InfluentialElghfar, M. H. M. A., Gelany, S. E., Ahmed, M., Rashed, M. A. A., Mohammed, I. Y. T. A. M., & Ahmed, H. H. (2025) · Journal of Ultrasound · doi:10.1007/s40477-025-01104-w · Cited by 1
Halaj, M., Hanulíková, P., Lisova, S. S., Hašlík, L., Heřman, H., Prosová, B., & Krofta, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1933234 · Cited by 1
The potential risk factors of placenta increta and the role of octamethylcyclotetrasiloxane
Long, Y., Jiang, M., Gao, F., Han, M., Gan, Q., Zeng, F., Zeng, S., Hu, Y., Dong, X., Ye, W., et al. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06335-w · Cited by 2
Kharisma, Y., Agustina, H., Suryanti, S., Dewayani, B. M., & Hernowo, B. S. (2025) · Jurnal Kesehatan Andalas · doi:10.25077/jka.v11i2.2063 · Cited by 3
Implications of multiple cesarean deliveries
Silver, R. M., & Sharshiner, R. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.829709
New insights in the diagnosis of placenta accreta
Hristiana, C., Mihalcean, L., Iurie, D., & Porfire, L. (2017) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/1812-2892-jcmk-00527
“After the delivery of the neonate, placenta does not separate spontaneously, and cannot be removed without causing abnormal usually masive obstetrical bleeding [7].”
BackgroundRefaat, M. M., Salem, A., Assy, M. M., & Abdelrazik, A. E. (2020) · Zagazig University Medical Journal · doi:10.21608/zumj.2020.23224.1716
Güzin, K., Özer, A., & Hansu, İ. (2020) · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · doi:10.17517/ksutfd.753770
Metadata
- Authors
- Balayla, J., & Bondarenko, H. D.
- Affiliations
- Université de Montréal (CA)
- Corresponding author
- Balayla, Jacques
- ORCID
- Balayla, Jacques
- Venue
- jpme
- Publisher
- Walter de Gruyter GmbH
- Published
- 2012-12-15
- Volume
- 41
- Issue
- 2
- Pages
- 141-149
- ISSN
- 0300-5577 (ISSN-L)
- 1619-3997
- OpenAlex
- W2004529751
- Cited by
- 128
- References
- 37
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 16 · 2022: 9 · 2021: 13 · 2020: 14 · 2019: 10 · 2018: 16 · 2017: 11 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 5
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Perinatal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- placenta accreta, placenta accreta spectrum, risk factors, maternal outcomes, neonatal outcomes, cesarean section, low-lying placenta, in vitro fertilization, alpha-fetoprotein, beta-hCG, postpartum hemorrhage, hysterectomy, maternal mortality, preterm birth, low birth weight, Apgar score, perinatal mortality, prenatal diagnosis
- MeSH terms
- Cesarean Section, Female, Postpartum Hemorrhage, Humans, Hysterectomy, Infant, Newborn, Placenta Accreta, Placenta Previa, Pregnancy, Pregnancy Outcome, Prenatal Diagnosis, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.